- Home
- GHG vs DCTH Comparison
GHG vs DCTH Comparison
Compare GHG & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHG
- DCTH
- Stock Information
- Founded
- GHG 2004
- DCTH 1988
- Country
- GHG China
- DCTH United States
- Employees
- GHG N/A
- DCTH N/A
- Industry
- GHG Hotels/Resorts
- DCTH Medical/Dental Instruments
- Sector
- GHG Consumer Discretionary
- DCTH Health Care
- Exchange
- GHG Nasdaq
- DCTH Nasdaq
- Market Cap
- GHG 202.0M
- DCTH 426.3M
- IPO Year
- GHG 2018
- DCTH N/A
- Fundamental
- Price
- GHG $2.33
- DCTH $11.86
- Analyst Decision
- GHG
- DCTH Strong Buy
- Analyst Count
- GHG 0
- DCTH 4
- Target Price
- GHG N/A
- DCTH $24.00
- AVG Volume (30 Days)
- GHG 11.9K
- DCTH 873.0K
- Earning Date
- GHG 08-14-2025
- DCTH 08-04-2025
- Dividend Yield
- GHG 4.29%
- DCTH N/A
- EPS Growth
- GHG N/A
- DCTH N/A
- EPS
- GHG 0.15
- DCTH N/A
- Revenue
- GHG $184,055,595.00
- DCTH $53,850,000.00
- Revenue This Year
- GHG $19.02
- DCTH $155.42
- Revenue Next Year
- GHG $8.26
- DCTH $37.93
- P/E Ratio
- GHG $15.70
- DCTH N/A
- Revenue Growth
- GHG N/A
- DCTH 1068.87
- 52 Week Low
- GHG $1.93
- DCTH $7.17
- 52 Week High
- GHG $3.40
- DCTH $18.23
- Technical
- Relative Strength Index (RSI)
- GHG 59.62
- DCTH 32.83
- Support Level
- GHG $1.97
- DCTH $12.11
- Resistance Level
- GHG $2.40
- DCTH $14.15
- Average True Range (ATR)
- GHG 0.11
- DCTH 0.57
- MACD
- GHG 0.03
- DCTH -0.16
- Stochastic Oscillator
- GHG 76.00
- DCTH 9.67
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.